Early Disease Detection Suppliers Serving Belarus

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

Applied Nanodetectors was formed in 2004 and is a leading developer and supplier of nanosensor based solutions for environmental, healthcare and medical worldwide markets. Improving peoples quality of life with our products. Dedicated to delivering ...

We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...

Menssana Research is the leading developer of advanced new breath tests for detection of disease. Early detection of diseases can often bring huge benefits: some cancers can be completely eradicated if they are detected early and treated promptly. ...

Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...

We are a multidisciplinary team of clinicians, technologists and behavioural experts who have come together to solve some of the biggest challenges in healthcare. Building on multi-year clinical studies on the impact of patient reported symptoms on ...

Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...

Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...

In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen ...

Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...

Hygiena delivers rapid microbial detection, monitoring, and identification solutions to a wide range of industries, including food and beverage, health care, hospitality, pharmaceuticals, and personal care. Utilizing advanced technologies and ...

Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. The ability to listen is the ability to care. Eko understands how important listening can be for ...

20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...

Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to ...

Novel point-of-care diagnostics for earlier disease detection. SANO Diagnostics is developing a range of disposable, cost-effective point-of-care diagnostics to detect the early onset of inflammation in several disease states. We are a development ...

Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...

Create a revolution in medical imaging through our advanced Computed Tomography technology. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are ...

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...

Fassisi GmbH is a manufacturer and developer of on-site rapid test systems, with a focus on the veterinary sector. The quality of our iVD products results from our more than 10 years of experience in the development and production of rapid test ...